Cargando…
SUN-449 Medical versus Surgical Treatment of Macroprolactinomas (MP): Indications, Efficacy, and Safety
Introduction: Prolactinomas are primarily treated with medical therapy. Given the efficacy of dopamine agonists (DAs), surgery has remained a second-line treatment option. Objective: to evaluate the indications, efficacy, and safety of both treatments in MP. Methods: We performed a retrospective ana...
Autores principales: | Cuccia, Mariela, Carrillo, Ana, Calvar, Cecilia, Figurelli, Silvina, Lescano, Sebastian, Guevara, Martin, Gardella, Javier, Gloria, Tubert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553332/ http://dx.doi.org/10.1210/js.2019-SUN-449 |
Ejemplares similares
-
SAT-449 Retrospective Study in Giant Adenomas (GA): Our Experience
por: Cuccia, Mariela, et al.
Publicado: (2019) -
SUN-444 Efficacy and Safety of Dopamine Agonists in Psychiatric Patients Treated with Antipsychotics and Presenting a Macroprolactinoma
por: Allard, Lucie, et al.
Publicado: (2019) -
SUN-446 Association between Prolactin Level and Tumor Size Reduction at 3 Months after Cabergoline Treatment in Patients with Macroprolactinoma
por: Kim, Daham, et al.
Publicado: (2019) -
A Challenging Case of Pituitary Macroprolactinoma During Pregnancy
por: Zainal, Abir, et al.
Publicado: (2021) -
Macroprolactinoma in a Patient With Schizophrenia: A Therapeutic Challenge
por: Voelz, Eduardo, et al.
Publicado: (2021)